この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1994/6/31 分で読めます
Skin Protectant Drug Products for Over-The-Counter Human Use; Astringent Drug Products; Final Monograph
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is issuing a final rule amending the monograph for over-the-counter (OTC) astringent drug products. This amendment updates the monograph to incorporate a United States Pharmacopeia (U.S.P.) name change for an active ingredient included in the monograph. This final rule is part of the ongoing review of OTC drug products conducted by FDA.
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →